March 31, 2022 — Konica Minolta Healthcare Americas, Inc. is pleased to announce the appointment of Fumihiko Hayashida as the company’s new President and CEO, effective April 1, 2022. Fumi will succeed David Widmann, who is retiring at the end of the company’s fiscal year on March 31.

March 31, 2022 — One of the essential roles of the forensic anthropologist is the development of a biological profile from a skeleton, which includes the estimation of assigned sex, age, stature and possibly ancestry or population affinity (skeletal characteristics associated with groups of people).

March 31, 2022 — Aidoc, a leading provider of healthcare AI solutions, announced that it received FDA 510(k) clearance for its triage and notification of pneumothorax on X-ray exams. A one-stop partner for the enterprise’s clinical AI needs, Aidoc’s other seven FDA-cleared solutions are already implemented across U.S.

March 31, 2022 — A major new study in Radiology shows that artificial intelligence (AI) is a promising tool for breast cancer detection in screening mammography programs.

March 30, 2022 — Artificial intelligence (AI) is an effective tool for fracture detection that has potential to aid clinicians in busy emergency departments, according to a study in Radiology.

March 30, 2022 — Breast density notifications aim to educate women about the risks of high breast density, defined as having more fibroglandular tissue than fatty tissue, as visualized on a mammogram. Prompted by activists whose own breast density had obscured breast cancers on their mammograms, 38 U.S.

March 30, 2022 — A study led by UC Davis Health has found that half of all women will experience at least one false positive mammogram over a decade of annual breast cancer screening with digital breast tomosynthesis (3D mammography). The risk of false positive results after 10 years of screening is considerably lower in women screened every other year.

March 29, 2022 — Some people recovering from COVID-19 pneumonia have CT evidence of damage to their lungs that persists a full year after the onset of symptoms, according to a new study published in the journal Radiology.

March 29, 2022 — “The Fundamental Flaws of the Canadian National Breast Screening Study (CNBSS) Trials: A Scientific Review,” authored by Seely, et al and published on March 29, 2022 in the Journal of Breast Imaging, reinforces criticism directed towards the CNBSS trials.

March 29, 2022 — GE Healthcare announced the first patient dosed in the Phase III clinical trial for a Positron Emission Tomography (PET) radiopharmaceutical imaging agent which aims to assist in the evaluation of adult patients with suspected Parkinsonian syndromes, support research and improve patient care. Already a global leader with DaTscan ([123I]-i

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now